Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04618952Phase 4Completed
Phase 4, randomised, triple-blind trial in hypertension (HTN), sponsored by Shiraz University of Medical Sciences. Primary endpoints: Mean systolic blood pressure in 24 hours at 60 days, Mean diastolic blood pressure in 24 hours at 60 days and 1 more. Started Jan 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04618952.